Transcend Capital Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $341K | Buy |
|
|||||
|
2025
Q1 | $358K | Buy |
|
|||||
|
2024
Q4 | $239K | Sell |
|
|||||
|
2024
Q3 | $400K | Buy |
|
|||||
|
2024
Q2 | $402K | Sell |
|
|||||
|
2024
Q1 | $407K | Sell |
|
|||||
|
2023
Q4 | $381K | Buy |
|
|||||
|
2023
Q3 | $337K | Buy |
|
|||||
|
2023
Q2 | $333K | Sell |
|
|||||
|
2023
Q1 | $421K | Sell |
|
|||||
|
2022
Q4 | $490K | Sell |
|
|||||
|
2022
Q3 | $555K | Sell |
|
|||||
|
2022
Q2 | $643K | Sell |
|
|||||
|
2022
Q1 | $656K | Sell |
|
|||||
|
2021
Q4 | $663K | Sell |
|
|||||
|
2021
Q3 | $644K | Buy |
|
|||||
|
2021
Q2 | $511K | Buy |
|
|||||
|
2021
Q1 | $472K | Sell |
|
|||||
|
2020
Q4 | $437K | Buy |
|